- Market Capitalization, $K 1,077,618
- Shares Outstanding, K 129,056
- Annual Sales, $ 5,748 M
- Annual Income, $ 60,600 K
- 60-Month Beta 2.48
- Price/Sales 0.18
- Price/Cash Flow 4.20
- Price/Book 0.75
|Period||Period Low||Period High||Performance|
| || |
-0.79 (-8.52%)since 02/08/21
| || |
+0.26 (+3.16%)since 12/08/20
| || |
+2.04 (+31.68%)since 03/06/20
Celestica (CLS) has been struggling lately, but the selling pressure may be coming to an end soon
Plexus (PLXS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
, /PRNewswire/ -- Lithium is now a critical metal for . In , the EU added lithium to its Critical Raw Materials (CRMs) list, warning of the need for a continuous flow of lithium supply for zero-emission...
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...
P/B ratio is emerging as a convenient tool for identifying low-priced stocks that have high growth prospects.
Let's see if Celestica (CLS) stock is a good choice for value-oriented investors right now from multiple angles.
Zacks.com featured highlights include: Sanmina Corp, Canadian Solar, Celestica and Alexion Pharmaceuticals
Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. Sanmina Corporation (SANM), Canadian Solar (CSIQ), Celestica (CLS) and Alexion Pharmaceuticals (ALXN)...
Top Ranked Growth Stocks to Buy for February 9th
Top Ranked Growth Stocks to Buy for February 5th
|GS Activebeta EM Equity ETF|
|Xtrackers MSCI EM ESG Leaders Equity ETF|
|Purebetasm FTSE Emerging Markets Invesco ETF|
|Intl Div Appreciation ETF Vanguard|
|FTSE EM ETF Vanguard|